These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3135966)

  • 61. Antibodies to hepatitis delta virus cannot be detected in carriers of hepatitis B surface antigen in Wuhan area (PR China).
    Gmelin K; Theilmann L; Bernhardt R; Kommerell B; Deinhardt F; Roggendorf M; Hao LJ
    J Tongji Med Univ; 1986; 6(3):198. PubMed ID: 3773018
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevalence of anti-delta antibodies in chronic HBsAg carriers in Czechoslovakia.
    Stránský J; Jezek P; Zichová M; Kolácný I; Horák Z; Vodák M; Chalupa P
    Infection; 1989; 17(4):252. PubMed ID: 2788620
    [No Abstract]   [Full Text] [Related]  

  • 63. A long-term follow-up of five patients with hepatitis delta virus in Japan.
    Koda T; Tamura I; Ichimura H; Murakami S; Takezaki E; Kurimura O; Kurahori T
    J Int Med Res; 1991; 19(6):484-92. PubMed ID: 1773909
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis delta virus infections in intravenous drug abusers with hepatitis B in the west of Scotland.
    McCruden EA; Follett EA
    J Med Virol; 1989 Sep; 29(1):59-62. PubMed ID: 2584958
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups.
    Siebke JC; von der Lippe B; Hansson BG; Nordenfelt E; Degré M
    Scand J Infect Dis; 1986; 18(1):33-6. PubMed ID: 3961420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nosocomial transmission of delta hepatitis.
    Lettau LA; Alfred HJ; Glew RH; Fields HA; Alter MJ; Meyer R; Hadler SC; Maynard JE
    Ann Intern Med; 1986 May; 104(5):631-5. PubMed ID: 3963662
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of a commercial anti-delta EIA kit for detection of antibodies to hepatitis delta virus.
    Govindarajan S; Valinluck B; Lake-Bakkar G
    Am J Clin Pathol; 1991 Feb; 95(2):240-1. PubMed ID: 1992616
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine.
    Kunches LM; Craven DE; Werner BG
    Am J Med; 1986 Oct; 81(4):591-5. PubMed ID: 3766588
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The delta agent in acute and chronic hepatitis B infection in Sweden.
    Norkrans G; Hermodsson S; Iwarson S
    Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of five hepatitis delta virus marker assays for detection of antigen and antibody.
    Bezeaud A; Rosenswajg M; Guillin MC
    J Clin Microbiol; 1989 Dec; 27(12):2880. PubMed ID: 2687325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence of anti-HIV and anti-delta among deferred HBsAg-positive volunteer blood donors.
    deMedina MD; Jeffers LJ; Reddy KR; Villanueva SY; Brendal W; Lenes B; Tomasulo P; Schiff ER
    Ann Intern Med; 1987 Aug; 107(2):256-7. PubMed ID: 3474916
    [No Abstract]   [Full Text] [Related]  

  • 72. Antibody to anti-delta in 218 hospitalized HBsAg carriers in Belgium.
    Cornu C; Lamy ME; Broes M; Peers M
    Acta Clin Belg; 1988; 43(1):62-8. PubMed ID: 3284265
    [No Abstract]   [Full Text] [Related]  

  • 73. Ethnic differences in the prevalence of hepatitis delta agent in Djibouti.
    Abbatte EA; Fox E; Said-Salah ; Constantine NT; Wassef HH
    Trans R Soc Trop Med Hyg; 1989; 83(1):107-8. PubMed ID: 2603184
    [No Abstract]   [Full Text] [Related]  

  • 74. Acute viral hepatitis in chronic carriers of hepatitis B virus: different patterns in different places.
    Lok A
    Hepatology; 1989 Aug; 10(2):252-3. PubMed ID: 2744733
    [No Abstract]   [Full Text] [Related]  

  • 75. Hepatitis B infection and renal transplantation: the absence of anti-delta antibodies and the possible beneficial effect of silymarin during acute episodes of hepatic dysfunction.
    Chan MK; Chan PC; Wong KK; Cheng IK; Li MK; Chang WK
    Nephrol Dial Transplant; 1989; 4(4):297-301. PubMed ID: 2502738
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The etiology of acute hepatitis in adults in Egypt.
    Zakaria S; Goldsmith RS; Kamel MA; el-Raziky EH
    Trop Geogr Med; 1988 Oct; 40(4):285-92. PubMed ID: 2852410
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of antibody to delta hepatitis virus in population groups in West Germany and Switzerland.
    Frösner GG; Franco E; Altorfer J; Decker RH; Mushahwar IK
    Eur J Clin Microbiol; 1985 Apr; 4(2):147-9. PubMed ID: 3924603
    [No Abstract]   [Full Text] [Related]  

  • 78. Anti-delta antibodies in commercial immunoglobulin preparations.
    Arankalle VA; Ramamoorthy CL; Dhorje SP; Pavri KM
    Indian J Med Res; 1988 Feb; 87():194-6. PubMed ID: 3397151
    [No Abstract]   [Full Text] [Related]  

  • 79. Observations on the serologic window in acute HDV.
    Decker RH; McNamara AL
    Prog Clin Biol Res; 1991; 364():159-64. PubMed ID: 2020691
    [No Abstract]   [Full Text] [Related]  

  • 80. Prevalence of delta agent among Canadian blood donors.
    Buchner BK; Moore BP
    Transfusion; 1986; 26(4):400. PubMed ID: 3727017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.